Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8241606 | International Journal of Radiation Oncology*Biology*Physics | 2007 | 8 Pages |
Abstract
Conclusion: These data are the first to show that MVP may be a useful prognostic marker associated with radiotherapy resistance in a subgroup of patients with HNSCC.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Priyamal M.R.C.S., Catharine M. Ph.D., Nick F.R.C.R., Helen M.RSc., W. David J. Grad. I.S., Lynne Ph.D., Rufzan Ph.D., Philip Ph.D., Nalin Ph.D., Jarrod F.R.C.S., Ian Ph.D.,